TNF-Alpha rs1800629 Polymorphism Is Not Associated with HPV Infection or Cervical Cancer in the Chinese Population

PLOS ONE, Dec 2019

Background While HPV infection is the main cause of cervical cancer, genetic susceptibility to HPV infection is not well understood. Tumor necrosis factor alpha (TNF-alpha), involved in the defense against HPV infection, plays an important role in cervical cancer progression and regression. The aim of this study was to investigate the relationship between the TNF-alpha rs1800629 polymorphism and risk of HPV infection or cervical cancer. Methods Three groups were involved in this study of Chinese women. Group 1 consisted of 285 high risk HPV positive cervical cancer patients, Group 2, 225 high risk HPV positive patients without cervical cancer, and Group 3, 318 HPV negative women with no cervical cancer. Blood samples were obtained from all patients and genotyped by PCR-RLFP. Fifty randomly selected samples were further sequenced. Results The allele and genotype distributions of the TNF-alpha rs1800629 polymorphism were not significantly different between each of the groups (P>0.05). There are no significant relationship between rs1800629 polymorphism and high risk HPV infection (OR  = 0.649, 95% CI: 0.253–1.670, P = 0.371), cervical cancer (OR  = 0.993, 95% CI: 0.376–2.618, P = 0.988), or cervical cancer with HPV infection (OR  = 0.663, 95% CI: 0.250–1.758, P = 0.409). Conclusions We demonstrated that there is no association between TNF rs1800629 polymorphism and the HPV infection, or cervical cancer with HPV infection.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0045246&type=printable

TNF-Alpha rs1800629 Polymorphism Is Not Associated with HPV Infection or Cervical Cancer in the Chinese Population

et al. (2012) TNF-Alpha rs1800629 Polymorphism Is Not Associated with HPV Infection or Cervical Cancer in the Chinese Population. PLoS ONE 7(9): e45246. doi:10.1371/journal.pone.0045246 TNF-Alpha rs1800629 Polymorphism Is Not Associated with HPV Infection or Cervical Cancer in the Chinese Population Ning Wang 0 Duo Yin 0 Shulan Zhang 0 Heng Wei 0 Shizhuo Wang 0 Yang Zhang 0 Yanming Lu 0 Shuyan Dai 0 Wei Li 0 Qiao Zhang 0 Yao Zhang 0 Cordula M. Stover, University of Leicester, United Kingdom 0 1 Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University , Shenyang , China , 2 Department of Breast Surgery, Shengjing Hospital of China Medical University , Shenyang , China Background: While HPV infection is the main cause of cervical cancer, genetic susceptibility to HPV infection is not well understood. Tumor necrosis factor alpha (TNF-alpha), involved in the defense against HPV infection, plays an important role in cervical cancer progression and regression. The aim of this study was to investigate the relationship between the TNFalpha rs1800629 polymorphism and risk of HPV infection or cervical cancer. Methods: Three groups were involved in this study of Chinese women. Group 1 consisted of 285 high risk HPV positive cervical cancer patients, Group 2, 225 high risk HPV positive patients without cervical cancer, and Group 3, 318 HPV negative women with no cervical cancer. Blood samples were obtained from all patients and genotyped by PCR-RLFP. Fifty randomly selected samples were further sequenced. Results: The allele and genotype distributions of the TNF-alpha rs1800629 polymorphism were not significantly different between each of the groups (P.0.05). There are no significant relationship between rs1800629 polymorphism and high risk HPV infection (OR = 0.649, 95% CI: 0.253-1.670, P = 0.371), cervical cancer (OR = 0.993, 95% CI: 0.376-2.618, P = 0.988), or cervical cancer with HPV infection (OR = 0.663, 95% CI: 0.250-1.758, P = 0.409). Conclusions: We demonstrated that there is no association between TNF rs1800629 polymorphism and the HPV infection, or cervical cancer with HPV infection. - Funding: This study was supported by the National Nature Science Foundation of China (No. 30973191), Science and Technology Program of Liaoning Province (No.2008225004), Peak Medical Construction Special Project of Liaoning Province (No.2010696), Science and Technology Program of Shenyang City (No.F11-2629-15) and Free Researcher Project of Shengjing Hospital (No.200806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. Cervical cancer remains the second most common cancer among women worldwide [1]. Infection by an oncogenic human papillomavirus (HPV) is a risk factor for developing cervical cancer [2]. Immune responses to HPV infection within the cervical epithelium play an important role in the pathogenesis of cervical cancer. Several cytokines that modulate the immunologic response have been implicated in the development of cancer [3]. Tumor necrosis factor-alpha (TNF-a), secreted mainly by activated macrophages, is an extraordinarily pleiotropic cytokine with a central role in immune homeostasis, inflammation, and host defense [4,5]. TNFa is involved in the defense against HPV infection, modulating viral replication [6]. The role of TNF-a in cancer is not well understood. Deregulated TNF expression within the tumor microenvironment appears to favor malignant cell tissue invasion, migration, and ultimately metastasis formation [7]. There is also evidence, however, that TNF-a may promote the development and spread of the cancer [8,9]. The role of TNF-a in tumor promotion is supported by the TNF-a-deficient mouse model, in which TNFa2/2 mice are resistant to the development of benign and malignant skin tumors. TNF modulation may contribute to regulation of cell inflammation, and the subsequent development of malignant disease [10]. Since the malignant development of cervical cancer is induced by persistent viral infection, we focus on the TNF gene, which may be involved in the susceptibility to HPV infection and development of cervical cancer. TNF-a is regulated at the transcriptional level [11] and the rs1800629 polymorphisms within the TNF-a promoter region have been associated with the level of TNF-a [12]. The association of rs1800629 polymorphism and cervical cancer has been widely studied, but the results are contradictory [13,14,15,16]. The current study was conducted to investigate the distribution of Group 1 (n = 285) Group 2 (n = 225) Group 3 (n = 318) Clinical stage* Note: * According to the International Federation of Gynecology and Obstetrics classification. doi:10.1371/journal.pone.0045246.t001 rs1800629 polymorphism and its relationship with HPV infection and cervical cancer. Materials and Methods Study subject (...truncated)


This is a preview of a remote PDF: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0045246&type=printable

Ning Wang, Duo Yin, Shulan Zhang, Heng Wei, Shizhuo Wang, Yang Zhang, Yanming Lu, Shuyan Dai, Wei Li, Qiao Zhang, Yao Zhang. TNF-Alpha rs1800629 Polymorphism Is Not Associated with HPV Infection or Cervical Cancer in the Chinese Population, PLOS ONE, 2012, Volume 7, Issue 9, DOI: 10.1371/journal.pone.0045246